Eva Ellebæk

Medicin og biovidenskab

1. Melanoma 100%
2. Tumor-Infiltrating Lymphocytes 29%
3. Survival 22%
4. Immunotherapy 22%
5. Dendritic Cells 21%
6. Nivolumab 20%
7. Cell- and Tissue-Based Therapy 20%
8. Vaccination 19%
9. T-Lymphocytes 18%
10. Therapeutics 16%
11. Indoleamine-Pyrrole 2,3,-Dioxygenase 14%
12. Neoplasms 11%
13. Interleukin-2 11%
14. Cyclophosphamide 10%
15. Phosphatidylethanolamine Binding Protein 8%
16. Antigens 8%
17. Ipilimumab 8%
18. tofacitinib 8%
19. Proto-Oncogene Proteins c-raf 8%
20. Adoptive Transfer 8%
21. Cancer Vaccines 7%
22. Fecal Microbiota Transplantation 7%
23. T-Cell Antigen Receptor Specificity 7%
24. Clinical Trials 7%
25. Enterocolitis 7%
26. Combined Vaccines 7%
27. Vaccines 7%
28. Uveal melanoma 7%
29. Mitogen-Activated Protein Kinase Kinases 7%
30. Positron Emission Tomography Computed Tomography 6%
31. Recurrence 6%
32. Databases 6%
33. Synthetic Vaccines 6%
34. Denmark 6%
35. Enteritis 6%
36. Subunit Vaccines 6%
37. Epitopes 6%
38. Confidence Intervals 6%
39. Cardiotoxicity 6%
40. Translational Medical Research 6%
41. Docetaxel 6%
42. Castration 5%
43. Progression-Free Survival 5%
44. Population 5%
45. Colitis 5%
46. Neoplasm Antigens 5%
47. Skin 5%
48. pembrolizumab 5%
49. Positron-Emission Tomography 5%